We identified specific H3K4 and H3K9 methyltransferases, such as Mll, Mll3, Setd1a, Ehmt2, Suv39h1, and Setdb1 as biomarkers of residual tumor cells persisting after chemotherapy. Here, KMT2C is linked to neoplasm.